Carregant...
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
BACKGROUND: The 5-year survival rate of patients with hepatocellular cancer (HCC) was very low because of invasion and metastasis in the early stage. Biomarkers might help predict early occurrence of invasion and metastasis. Accumulating evidence has shown that deleted in liver cancer-1 (DLC1) may b...
Guardat en:
| Publicat a: | Diagn Pathol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4743322/ https://ncbi.nlm.nih.gov/pubmed/26846339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0470-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|